Author

Samuele Mercan

Novartis (Switzerland)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Alyssa Synan· 1 shared Andrew R. GreeniD· 1 shared Anthony S. Malamas· 1 shared Claude Logel· 1 shared Dominik Hainzl· 1 shared Joseph A. D’Alessio· 1 shared Joshua M. KorniD· 1 shared Kathleen T. XieiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alyssa Synan

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A bispecific antibody-drug conjugate targeting pCAD and CDH17 has antitumor activity and improved tumor specificity

Alyssa Synan, Nila C. Wu, Roberto Velazquez, Thomas G. Gesner, Claude Logel, Kathrin Mueller, Andrew R. Green, Patrizia Barzaghi-Rinaudo, Quincey Simmons, Samuele Mercan, Xingyi Shi, Xun Li, Vivek Sagar, Joshua M. Korn, Margaret E. McLaughlin, , Joseph A. D’Alessio

This study develops a bispecific antibody-drug conjugate targeting pCAD and CDH17, showing antitumor activity in dual antigen-expressing tumors but not in single antigen-expressing tumors.

mAbs · Jan 6, 2025Peer-reviewedCancer Biology